1Esteban J, Robert D, Costanzo A, et al. Lung cancer and cyclooxygenase-2[J]. Ann Thorac Surg,2003,76(4) : 1327-1335.
2Khuri FR, Wu H, Lee JJ, et al. Cyclooxygenase-2 overexpression is a marker of prog nosis in stage I non-smaU cell lung cancer[J]. Clin Cancer Res, 2001,7 (4) : 861-867.
3Brabender J, Park J, Metzger R, et al. Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer [J].Ann Surg,2002,235(3) :440-443.
5Lin MT, Lee RC, Yang PC, et al. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway [ J ]. J Biol Chem, 2001,276 (52) :48997-49002.
6Masferrer JL, Leahy KM, Koki AT, et al. Antiangeogenic and antitumor activities of cyclooxygenase-2 inhibitors[J] .Cancer Res,2000,60(5) :1306-1311.
7Dohadwala M, Luo J, Zhu L, et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44 [ J ]. J Biol Chem,2001,276(.24) :20809-20812.
8Nakata H, Uemura Y, Kobayashi M, et al. Cyclooxygenase-2 inhibtor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and GMCsf in lung cancer cells[J]. Cancer Sci ,2003,94(12) : 173-180.
9Mulshine J,Malkani S,Chung P, et al. Non-small cell lung cancer cycloxygenase activity and proliferation [ J ]. Anticancer Res, 1998, 18( 2 A ) : 775 -782.
10Eli Y, Przedecki F, Levin G, et al. Comparative effects of indomethacin on cell proliferation and progression in tumor cell grown in vitro and vivo[ J ]. Biochem Pharmacol, 2001,61 (5) : 565-571.
